Skip to content
Peptigraph home

Semax for ADHD: What the Evidence Shows

What human and animal studies show about Semax for ADHD, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureACTH(4-10) analogUpdated
Strongest evidence
None graded
no study with an outcome for ADHD (PubMed search, 2 Oct 2026)
Human studies
1
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger
Studies we summarised
1
with an outcome for ADHD

Evidence for ADHD

Each row is an outcome related to ADHD from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Semax for ADHD: outcomes in published studies
OutcomeResultStudy typeSource
ADHD (hypothesis only)The authors propose, without new data, that semax may help ADHD.ReviewMedical hypotheses 2007, PMID 16996699

PubMed records for Semax and ADHD: 1 human, 0 animal (search counts, not studies we reviewed). Grades follow our evidence scale.

How strong is it?

Strongest evidence:No graded study for ADHD (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for ADHD

TirzepatideSemaglutide
All peptides for ADHD, compared

Common questions

Does Semax help with ADHD?

None of the studies we summarised for Semax (PubMed search, 2 Oct 2026) measured an outcome for ADHD. Treat claims that it helps with ADHD as unproven.

Is Semax approved for ADHD?

No. Semax is not FDA approved for any use, including ADHD.

What is the best peptide for ADHD?

There is no single answer. Our ADHD overview compares each candidate by evidence grade and legal status rather than by popularity.

More on Semax

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.Half-lifeWhat is measured, by route, and what is not.

Sources

  1. 1Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.Medical hypotheses · 2007PMID 16996699Accessed 2 Oct 2026

Found an error? Report a correction.